Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1946]
News [3597]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Recent advances in site specific conjugations of antibody drug conjugates
Recent advances in site specific conjugations of antibody drug conjugates
Researchers identify potential immunotherapy drug combination
Researchers identify potential immunotherapy drug combination
Results of first study assessing clinical impact of ESMO magnitude of clinical benefit scale
Results of first study assessing clinical impact of ESMO magnitude of clinical benefit scale
PD-1 improves antitumour vaccine response in glioblastoma model
PD-1 improves antitumour vaccine response in glioblastoma model
Everolimus R-CHOP combination safe for treating diffuse large B-cell lymphoma
Everolimus R-CHOP combination safe for treating diffuse large B-cell lymphoma
NICE turns down nivolumab for kidney cancer, citing cost
NICE turns down nivolumab for kidney cancer, citing cost
Radiotherapy enhancer boosts immunotherapy response
Radiotherapy enhancer boosts immunotherapy response
Last Month in Oncology with Dr Bishal Gyawali: June 2016
Last Month in Oncology with Dr Bishal Gyawali: June 2016
Dividing T cells: A potential target for improving cancer immunotherapy
Dividing T cells: A potential target for improving cancer immunotherapy
New anti-cancer strategy mobilizes both innate and adaptive immune response
New anti-cancer strategy mobilizes both innate and adaptive immune response

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation